Treatment with Adcirca (tadalafil) plus Opsumit (macitentan) can provide functional benefits and lessen symptoms in newly diagnosed patients…
Articles by Alice Melão, MSc
Respira Therapeutics has regained full worldwide research, development, and licensing rights over its inhaled medicine-device combination product, called…
Pulmonary hypertension contributes to markedly poorer outcomes and doubles a risk of death in people with moderate-to-severe problems in…
Oral treatment with rodatristat ethyl is safe and well-tolerated, according to results from two completed Phase 1 clinical studies…
An enzyme involved in DNA damage processes, called EYA3, contributes to structural changes in lung blood vessels and to the…
Translate Bio is focusing its efforts on the development of new therapies targeting pulmonary diseases, including pulmonary arterial…
A rise in the volume of red blood cells may help to identify people with chronic obstructive pulmonary disease…
Analysis of gas exhaled in differing positions, like sitting or laying flat, could be a noninvasive and simple alternative to…
While physicians worldwide are conducting multi-parametric risk assessments to evaluate pulmonary arterial hypertension (PAH), they are not doing so…
Long-term use of Orenitram led to moderate but durable, and dose dependent, improvements in exercise capacity in pulmonary arterial hypertension…
Abbott’s CardioMEMS HF system — a wireless heart failure monitor — can be safely used to monitor blood…
A new generic version of Actelion’s Tracleer (bosentan) developed by Teva Pharmaceutical was approved by the…